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Extended abstract 17 
 18 
Study question: Which couples with unexplained subfertility can expect increased chances 19 
of ongoing pregnancy with in vitro fertilisation (IVF) compared to expectant management? 20 
 21 
Summary answer: IVF is associated with higher chances of conception than expectant 22 
management in couples in whom the female partner is under 40 years of age. In contrast, 23 
IVF is less effective in women aged over 40 and in couples with one year of secondary 24 
subfertility regardless of the age of the woman. 25 
 26 
What is known already: The clinical indications for IVF have expanded over time from 27 
bilateral tubal blockage to include unexplained subfertility in which there is no identifiable 28 
barrier to conception. Yet, there is little evidence from randomised controlled trials that IVF is 29 
effective in these couples. 30 
 31 
Study design, size, duration: We compared outcomes in British couples with unexplained 32 
subfertility undergoing IVF (n=40.921) from registry data to couples with the same type of 33 
subfertility on expectant management. The latter comprised a prospective nation-wide Dutch 34 
cohort (n=4.875) and a retrospective regional cohort from Aberdeen, Scotland (n=975). We 35 
excluded couples who had tried for less than a year to conceive and also those with 36 
anovulation, uni- or bilateral tubal occlusion, mild or severe endometriosis or male subfertility 37 
i.e. impaired semen quality according to WHO criteria. 38 
 39 
Participants/materials, setting, methods: 40 
We matched couples who received IVF and couples on expectant management based on 41 
their characteristics to control for confounding. We fitted a Cox proportional hazards model 42 
including patient characteristics, IVF treatment and their interactions to estimate the 43 
individualised chance of conception over one year – either following IVF or expectant 44 
management for all combinations of patient characteristics. The endpoint was conception 45 
leading to ongoing pregnancy defined as a foetus reaching a gestational age of at least 12 46 
weeks. 47 
 48 
Main results and the role of chance: The adjusted one year chance of conception was 49 
47.9% (95%CI: 45.0-50.9) after IVF and 26.1% (95%CI: 24.2-28.0) after expectant 50 
management. The absolute difference in the average adjusted one year chances of 51 
conception was 21.8% (95%CI: 18.3-25.3) in favour of IVF. 52 
The effectiveness of IVF was influenced by female age, duration of subfertility and previous 53 
pregnancy. IVF was effective in women under 40 years, but the chance of an IVF conception 54 
over one year declined sharply in women over 34. In contrast, in woman over 40 years of 55 
age, IVF was less effective, with an absolute difference in chance compared to expectant 56 
management of 10% or lower. Regardless of female age, IVF was also less effective in 57 
couples with a short period of secondary subfertility (1 year), who had chances of natural 58 
conception of 30% or above. 59 
 60 
Limitations, reasons for caution: The one year chances of conception were based on 61 
three cohorts with different sampling mechanisms. Despite adjustment for the three most 62 
important prognostic patient characteristics, namely female age, duration of subfertility and 63 
primary or secondary subfertility, our estimates might not be free from residual confounding. 64 
 65 
Wider implications of the findings: IVF should be used selectively in those who have the 66 
most to gain from active treatment over expectant management. Our results can be used by 67 
clinicians to counsel couples with unexplained subfertility, to inform their expectations and 68 
facilitate evidence-based, shared decision making. 69 
 70 
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Introduction 73 
Subfertility is defined as not conceiving within one year of regular unprotected intercourse 74 
and this affects approximately one in nine heterosexual couples (Datta et al., 2016). 75 
Following standard investigations, no cause can be identified in a third of these couples who 76 
are said to have unexplained subfertility. In vitro fertilisation (IVF), with or without intra-77 
cytoplasmic sperm injection (ICSI), is a commonly used treatment for couples with prolonged 78 
unresolved subfertility and over 470.000 treatment cycles were recorded in Europe in 2013 79 
(Calhaz-Jorge et al., 2017). IVF is a burden to couples in terms of mental and physical 80 
stress, is associated with high expectations and considerable investment in terms of 81 
emotions, finances and time (Rooney and Domar, 2016). The number of IVF cycles 82 
conducted increases annually, posing an increasing burden on health services in countries 83 
where IVF is publicly funded (HFEA, 2004; Andersen et al., 2007; NVOG, 2010; NICE, 2013; 84 
Kamphuis et al., 2014; Calhaz-Jorge et al., 2017; HFEA, 2018). This increase is generally 85 
considered to be the consequence of the increasingly liberal utilisation of IVF for a variety of 86 
indications including unexplained subfertility (HFEA, 2004; Kamphuis et al., 2014; HFEA, 87 
2015). Yet, there is little robust evidence supporting the effectiveness of IVF in couples with 88 
unexplained subfertility compared to a wait-and-see approach i.e. expectant management 89 
(Pandian et al., 2015; Tjon-Kon-Fat et al., 2016). 90 
There is a single trial evaluating the effectiveness of IVF versus expectant 91 
management for couples with unexplained subfertility in terms of live birth which reported the 92 
chance of live birth following IVF (11 out of 24 couples) to be12 times that of expectant 93 
management (1 out of 27 couples) (Hughes et al., 2004). Although the results seem to 94 
support IVF, there is considerable uncertainty around this result based on very small 95 
numbers of participants and it is inappropriate for clinical practice across the globe to be 96 
based on this quality of evidence (Tjon-Kon-Fat et al., 2016). 97 
Observational studies have separately quantified the predicted chances of conception 98 
after IVF and after a period of expectant management (Leushuis et al., 2009; McLernon et 99 
al., 2016; van Eekelen et al., 2017a). There are two problems that hamper the comparability 100 
of these predictions which currently limit their clinical utility. First, the prognoses were derived 101 
from separate studies with dissimilar patient characteristics. For instance, women with 102 
unexplained subfertility who received IVF are generally older than women who pursued 103 
expectant management. Second, the prognosis after IVF is expressed per embryo transfer or 104 
per complete IVF cycle while the prognosis associated with expectant management is 105 
expressed in terms of calendar time, commonly over one year (Daya, 2005). 106 
We can address these problems by adjusting for differences between couples who 107 
were treated with IVF and couples who pursued expectant management and expressing 108 
predicted chances over a uniform time horizon. To this end, we opted for a pragmatic 109 
approach by analysing data from three observational cohorts: the UK national IVF registry 110 
and two groups of couples (from the Netherlands and Scotland respectively) who embarked 111 
on a variable period of expectant management. 112 
Our aim was threefold: first to use individual patient data from these three cohorts to 113 
compare the average absolute unadjusted adjusted one year chance of conception after IVF 114 
or expectant management, second to compare the adjusted one year chance of conception 115 
after IVF or expectant management and third, to estimate the effectiveness of IVF in 116 
individual patients based on their clinical characteristics. 117 
 118 
 119 
Materials and Methods 120 
In short: the population comprised couples with unexplained subfertility seen in fertility 121 
clinics. The exposure was all IVF cycles and subsequent embryo transfers received within 122 
one year after the start of ovarian stimulation. The comparator in the unexposed group was 123 
expectant management for one year after completion of the fertility workup. The outcome of 124 
interest was conception leading to ongoing pregnancy. 125 
 126 
IVF cohort 127 
Data on couples treated with IVF between 1999 and 2011 were obtained from the Human 128 
Fertilisation and Embryology Authority (HFEA) registry which collects data from all licensed 129 
clinics in the United Kingdom (McLernon et al., 2016). From 2009 onwards, the number of 130 
women included was limited because explicit consent was required for the use of their data 131 
for research purposes (McLernon et al., 2016). 132 
 133 
Expectant management cohorts 134 
We combined data from two separate cohorts comprising couples with unexplained 135 
subfertility who underwent expectant management. The first was a prospective cohort 136 
assembled across 38 hospitals in The Netherlands between January 2002 and February 137 
2004. Couples were followed for natural conception from the completion of the fertility 138 
workup onwards. The detailed protocol for this has been described elsewhere (van der Steeg 139 
et al., 2007). The second was a retrospective population based cohort from the Grampian 140 
region of Scotland comprising subfertile couples who registered at Aberdeen Fertility Clinic. 141 
Using a unique, pseudonomised identifier, we linked patient records including demographic 142 
and diagnostic information from the fertility clinic to treatment records from Aberdeen 143 
Assisted Reproduction Unit Database and to pregnancy outcomes from the Aberdeen 144 
Maternity and Neonatal Databank (van Eekelen et al., 2018). This process was carried out 145 
according to the Standard Operating Procedures of the Data Management Team, University 146 
of Aberdeen. We selected couples living in the Aberdeen City District whose births occurred 147 
at Aberdeen Fertility Clinic. Pregnancy outcomes from natural conceptions were identified by 148 
linkage with the Aberdeen Maternity and Neonatal Databank which captures all birth 149 
outcomes in this region (Ayorinde et al., 2016). 150 
 151 
Inclusion and exclusion criteria 152 
Couples who had been trying for a pregnancy for less than one year, those with anovulation, 153 
uni- or bilateral tubal occlusion, mild or severe endometriosis and male subfertility i.e. 154 
impaired semen quality according to WHO criteria were excluded from the UK IVF and 155 
Scottish cohorts (WHO, 1999; WHO, 2010). For the Dutch cohort, the same exclusion criteria 156 
were applied, except that mild endometriosis was considered as a part of unexplained 157 
subfertility and male subfertility was defined as a total motile count below 1 million (van 158 
Eekelen et al., 2017a). 159 
 160 
Treatment protocols 161 
Decisions regarding treatment were based on local and national protocols. In short, the UK 162 
IVF registry comprises every IVF cycle with guidelines changing over time (NICE, 2013). 163 
Treatment decisions for the Dutch cohort were left to the discretion of physicians in 164 
agreement with their patients (NVOG, 2004; van der Steeg et al., 2007) and in the Scottish 165 
cohort by the local protocol and national guideline (NICE, 2013). 166 
Expectant management was defined as no intervention aside from the advice to have 167 
intercourse. 168 
 169 
Definitions for outcome and follow up 170 
Our outcome of interest was conception leading to an ongoing pregnancy, defined as a 171 
foetus reaching a gestational age of at least 12 weeks visualised by ultrasound. The date of 172 
conception was defined as the first day of the last menstruation period prior to conception. 173 
We analysed data up to a maximum of one year of follow up. 174 
Follow up for couples on expectant management started at completion of the fertility 175 
workup and ended, for those who did not conceive, at one year after the workup, on the date 176 
of last contact or the date of starting ovarian stimulation for IUI or IVF treatment (whichever 177 
came first) i.e. we censored their time-to-pregnancy. We assumed that couples who 178 
continued with expectant management were no different, in terms of their clinical 179 
characteristics and resulting prognosis, to those who were censored (non-informative 180 
censoring). 181 
Couples who received IVF were followed from the start of ovarian stimulation in the first cycle 182 
up until their last embryo transfer. Since the IVF registry contained all UK IVF cycles from 183 
1999 to 2011, all ongoing IVF pregnancies within a year of initiating the first cycle (i.e. all 184 
fresh and frozen cycles) were recorded and we thus had complete one year follow up during 185 
which couples received 1.5 embryo transfers on average. This assumes that couples who 186 
discontinued treatment had zero chance of conception after IVF afterwards, for instance for 187 
reasons related to an insufficient number of oocytes collected during follicle aspiration, a low 188 
fertilization rate or financial reasons (Daya, 2005). 189 
To align with our assumption of pursuing one full year of expectant management, we also 190 
considered the hypothetical scenario in which couples continued their IVF attempts for a full 191 
year of follow up during which they underwent 3 to 4 embryo transfers on average. In the 192 
supplementary analysis following this scenario, we censored time-to-pregnancy in couples 193 
receiving IVF after their last unsuccessful IVF transfer, defined as the first day of 194 
menstruation before the last embryo transfer. We thus also assumed non-informative 195 
censoring in IVF i.e. that couples who continued IVF were similar to couples who dropped 196 
out of IVF. 197 
 198 
Missing data 199 
To be able to compare couples who received IVF and couples who expectant management, 200 
we had to make assumptions around the dates of ovarian stimulation and first day of 201 
menstruation in couples who had IVF. As couples start their IVF treatment with ovarian 202 
stimulation, we elected to follow couples from that date until conception (the first day of last 203 
menstruation before the final embryo transfer) to align with the general definition of time to 204 
natural conception. Since dates of initiation of ovarian stimulation were not available in the 205 
UK IVF database and are not applicable to frozen/thawed cycles, we assumed a period of 15 206 
days before the date of embryo transfer (Alport et al., 2011). 207 
In the Dutch cohort, the date of workup completion could be derived and this date was used 208 
as the start of follow up (van Eekelen et al., 2017a). For the Scottish cohort, this date was not 209 
available and was estimated at six weeks after the date of registration, which was the 210 
average time between registration and completion of the fertility workup in the Dutch cohort. 211 
The prognostic patient characteristics that were recorded in all cohorts were female 212 
age, duration of subfertility and (female) primary or secondary subfertility. In the UK IVF 213 
cohort, data for primary or secondary subfertility from 2008 onwards (n=7532, 18%) were not 214 
systematically recorded and were considered as missing. Because of these missing values, 215 
we applied multiple imputation including all relevant prognostic characteristics and a 216 
covariate for the cumulative hazard of pregnancy to account for the aspect of time in the 217 
data, creating 10 imputation sets (White and Royston, 2009). In the Dutch cohort, fewer than 218 
1% of data used for the present study were missing and were accounted for in a previous 219 
study by multiple imputation, creating 10 imputation sets (van Eekelen et al., 2017a). In the 220 
Scottish cohort, fewer than 1% of data were missing and we applied multiple imputation 221 
identical to the approach in the UK IVF cohort. Ten imputation sets were thus created 222 
separately for the three cohorts, then combined to derive 10 combined datasets and we 223 
pooled their results using Rubin’s Rules (Rubin, 2004). 224 
 225 
Matching procedure 226 
To ensure that there was no confounding due to the three prognostic patient characteristics 227 
(female age, duration of subfertility and previous pregnancy), we applied matching (Austin, 228 
2014). In this matching procedure, we paired couples on expectant management to couples 229 
that received IVF that had the same (rounded) female age, duration of subfertility and 230 
primary or secondary subfertility status. We found all possible pairs with replacement which 231 
allows each patient to be used as a match more than once. This yields higher quality 232 
matches than matching without replacement due to data on all matches being used (Abadie 233 
and Imbens, 2006). Then, we weighted couples such that the expectant management group 234 
was the reference or ‘target population’. Thus, in the resulting complete ‘matched’ dataset, 235 
the average patient characteristics and sample size of couples on expectant management 236 
were now identical to couples who received IVF. Using this matched data, we estimate what 237 
would happen if couples on expectant management would instead start IVF (referred to as 238 
the average treatment effect in controls, or ATC) (Austin, 2014). 239 
 240 
Statistical analysis 241 
Average effect of IVF 242 
We calculated the unadjusted one year chance of conception after IVF as the observed 243 
fraction of couples who conceived within one year of IVF on the original, unmatched dataset. 244 
We estimated the unadjusted one year chance of conception after expectant management 245 
with the Kaplan-Meier method on the original, unmatched dataset. We calculated the 246 
average unadjusted effect as the absolute difference of these two chances. To estimate the 247 
adjusted chances and the adjusted average effect, we repeated both these analyses on the 248 
matched dataset. 249 
 250 
Individualised effectiveness of IVF 251 
We defined the individualised effectiveness of IVF as the absolute difference between the 252 
estimated one year chance of conception after IVF and the one year chance when pursuing 253 
expectant management for a couple based on female age, duration of subfertility and 254 
primary/secondary subfertility status. To estimate these individual chances, we fitted a Cox 255 
proportional hazards model on the original, unmatched dataset using treatment (IVF or 256 
expectant management), the patient characteristics and the interaction between treatment 257 
and patient characteristics as covariates. This was done following three steps. 258 
We first determined how female age and duration of subfertility could best be entered 259 
into our statistical model: we evaluated both linear and non-linear associations with the log 260 
hazard of conception using linear terms or restricted cubic splines, then tested which fitted 261 
better using Wald tests and Akaike’s Information Criterion (AIC) (Akaike, 1974; Harrell et al., 262 
1996). 263 
Once a suitable form for female age and duration of subfertility was determined, we 264 
included IVF treatment, female age, duration of subfertility, primary or secondary subfertility 265 
and all interaction terms with IVF treatment in the model to assess if the effect of IVF 266 
depended on these characteristics. We then tested all interaction terms simultaneously with 267 
an overall Wald test. If this test was significant, we performed backwards selection on the full 268 
model using Wald tests per separate interaction and AIC to determine which interaction was 269 
informative and removed those that were not (Akaike, 1974). We checked the proportional 270 
hazards assumption for all covariates in the model using scaled Schoenfeld residuals 271 
(Grambsch and Therneau, 1994) and accounted for the non-proportional hazard for IVF 272 
treatment versus expectant management by stratifying on treatment group. 273 
After the final model fit, we visualized the association between patient characteristics 274 
which varied the effect of IVF by estimating one year chances of conception for couples with 275 
different characteristics. 276 
In addition, we estimated chances for all combinations of patient characteristics, tabulating 277 
the estimated chances, their corresponding 95% confidence intervals (CIs), absolute 278 
differences, relative differences and the number needed to treat (NNT). 279 
 280 
Supplementary analyses 281 
In the first supplementary analysis, in order to estimate the outcome if couples would 282 
continue to have IVF over a full one year, we used the Kaplan-Meier method both for couples 283 
receiving IVF and for couples pursuing expectant management on the original and matched 284 
datasets. 285 
In the second supplementary analysis, we again estimated individualised chances after both 286 
IVF and expectant management but now expressed over a period of 6 months. We tabulated 287 
these 6 month chances as well as their corresponding 95% confidence intervals (CIs), 288 
absolute differences, relative differences and the number needed to treat (NNT). 289 
 290 
The study was approved by the North of Scotland Research Ethics Committee (17/NS/0122). 291 
Data linkage and all statistical analyses were performed in the Data Safe Haven of the 292 
University of Aberdeen using R version 3.4.3 (R Core Team (2017). R: A language and 293 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, 294 
Austria. http://www.R-project.org/) and RStudio using the survival package for the Kaplan-295 
Meier method, mice for multiple imputation of missing data, rms for functions for splines and 296 
fitting Cox models and Matching to conduct the matching by patient characteristics. 297 
 298 
 299 
Results 300 
Data from a total of 46.771 couples were available for analysis (Figure 1). Out of 40.921 301 
couples in the UK IVF cohort who received 61.019 embryo transfers in total, 16.281 302 
conceived (39.8% of couples, 26.7% per embryo transfer) within one year of starting IVF. 303 
32.396 (79%) couples received IVF and 8.525 (21%) received ICSI. There were 4.891 304 
multiple gestations after IVF (12% of couples, 30% of conceptions). Out of 4.875 couples in 305 
the Dutch cohort pursuing expectant management, 903 (18.5%) couples conceived naturally 306 
within one year after completion of the fertility workup. There were 11 multiple gestations 307 
(0.2% of couples, 1.2% of conceptions). Out of 975 couples in the Scottish cohort pursuing 308 
expectant management, 229 (23.5%) couples conceived naturally within one year after 309 
completion of the fertility workup. There were no multiple gestations. 310 
The median duration of follow up for couples receiving IVF was one embryo transfer (25th-311 
75th percentile: 0-7 months) as 29% of couples conceived after their first embryo transfer 312 
and 21% discontinued IVF treatment after their first unsuccessful embryo transfer. The 313 
median follow up for couples pursuing expectant management was 7 months (25th-75th 314 
percentile: 3-12 months). 315 
 316 
Patient characteristics 317 
The baseline characteristics of couples, stratified by cohort, are presented in Table I. In 318 
comparison with women who were managed expectantly, those who received IVF were older 319 
(mean 35.1 years in the UK IVF, 32.5 years in the Dutch and 33.2 years in the Scottish 320 
cohorts), had been trying to conceive for longer (median 4.0 years in UK IVF, 1.6 years in the 321 
Dutch and 2.1 years in the Scottish cohorts) but were just as likely to have primary subfertility 322 
(60% in the UK IVF, 66% in the Dutch and 59% in the Scottish cohorts). 323 
The distributions of female age and duration of subfertility for couples who received IVF and 324 
couples who pursued expectant management are shown in Figures 2A and B. 325 
 326 
Unadjusted average chance of conception 327 
The unadjusted one year chance of conception after starting IVF was 39.8% (95%CI: 39.3-328 
40.3) and after expectant management was 26.1% (95%CI: 24.7-27.5). The average 329 
absolute difference in the unadjusted one year chance of conception was 13.6% (95%CI: 330 
11.6-15.7) in favour of IVF. The one year chances following expectant management in the 331 
Dutch and Scottish cohorts were similar (26.9% and 23.8% respectively). 332 
 333 
Adjusted average chance of conception 334 
A total of 5.818 out of 5.850 (99%) couples pursuing expectant management were matched 335 
with 31.867 out of 40.921 (78%) counterparts who received IVF and had the same 336 
characteristics. The adjusted one year chance of conception was 47.9% (95%CI: 45.0-50.9) 337 
after starting IVF and 26.1% (95%CI: 24.2-28.0) after expectant management. The average 338 
absolute difference in the adjusted one year chance of conception was 21.8% (95%CI: 18.3-339 
25.3) in favour of IVF. 340 
 341 
Individualised effectiveness of IVF 342 
Both female age and duration of subfertility were non-linearly associated with conception 343 
(Wald tests for non-linearity both p<0.001, splines with 5 and 3 knots respectively). 344 
There were statistically significant interactions between all three patient characteristics and 345 
IVF treatment (overall p<0.001, individual interactions all p<0.001). 346 
The estimated effects of couple characteristics on conception in terms of hazard ratios (HRs) 347 
are presented in Table II. In general, as female age increased, the chance of conception 348 
decreased both after expectant management and after IVF, but the detrimental effect of 349 
female age above 34 years on the chance of conception was stronger in the latter (HR of 40 350 
versus 35 years: 0.43 after IVF and 0.64 after expectant management). As duration of 351 
subfertility increased, the chance of conception decreased in both groups, but this effect was 352 
stronger for those on expectant management (HR of 6 versus 2 years: 0.86 after IVF and 353 
0.39 after expectant management). Couples with primary subfertility on expectant 354 
management had a lower chance of conception compared to couples with secondary 355 
subfertility (HR of primary versus secondary: 0.71) but there was no noticeable difference in 356 
the IVF group (HR: 0.98). 357 
The predicted one year chance of conception in couples with primary subfertility of 2 358 
years duration and female age ranging between 26 and 42 are shown in Figure 3. The 359 
effectiveness of IVF decreased in women over 34 years. 360 
The predicted one year chances of conception in couples with primary subfertility where 361 
female age is 35 years and the duration of subfertility ranges from 1 to 8 years are visualised 362 
in Figure 4. The effectiveness of IVF increased as the duration of subfertility increased. 363 
The predicted one year chances of conception for couples with 2 year duration where female 364 
age is 35 years stratified for primary and secondary subfertility are presented in Table III. IVF 365 
was more effective for couples with primary subfertility than for couples with secondary 366 
subfertility. 367 
 368 
In Supplementary Material I, we present full tables containing the predicted one year 369 
chance of conception after IVF and after starting expectant management for all combinations 370 
of patient characteristics. Also provided are the absolute differences between these chances, 371 
the relative differences and the numbers needed to treat (NNT) to achieve one additional 372 
conception. 373 
For instance, a typical couple undergoing IVF, where the woman is 35 years old with 4 years 374 
duration of primary subfertility, has an estimated one year chance of conception of 46% 375 
(95%CI: 44-48) after IVF compared to 12% (95%CI: 9-14) after expectant management, with 376 
an absolute difference of 34% and a NNT of 2.9. 377 
On the other hand, a typical couple pursuing expectant management, where the woman is 33 378 
years old with 2 years of primary subfertility, has an estimated one year chance of 379 
conception of 53% (95%CI: 50-55) after IVF compared to 23% (95%CI: 20-25) after 380 
expectant management, with an absolute difference of 30% and a NNT of 3.3. 381 
In couples where the woman is under 40 years, IVF was effective compared to 382 
expectant management. In contrast, in couples where the woman is over 40 years, IVF was 383 
less effective as the absolute difference between chances was approximately 10% or lower. 384 
In couples with one year duration of secondary subfertility, regardless of the age of the 385 
woman, IVF was also less effective since their chances of natural conception remained 386 
relatively high at 30% or above. 387 
 388 
Supplementary analyses 389 
In the supplementary analysis where we estimated outcomes in couples who continued with 390 
IVF for a full year, the unadjusted one year chance of conception after IVF was estimated at 391 
51.6% (95%CI: 50.9-52.2). The average absolute difference in the unadjusted one year 392 
chance of conception became 25.4% (95%CI: 23.1-27.7) in favour of IVF. 393 
The adjusted one year chance of conception after receiving IVF for one full year was 394 
estimated at 59.7% (95%CI: 55.3-64.0). The average absolute difference in the adjusted one 395 
year chance of conception became 33.6% (95%CI: 28.8-38.3) in favour of IVF. 396 
In Supplementary Material II, we present the same individualised predictions as in 397 
Supplementary Material I but now expressed over 6 months instead of one year. 398 
 399 
 400 
Discussion 401 
In couples with unexplained subfertility, we found that IVF increased the average one year 402 
chance of conception compared to expectant management. Factors affecting the 403 
effectiveness of IVF were female age, duration of subfertility and primary/secondary 404 
subfertility. 405 
 406 
Although couples who received IVF had, on average, a higher female age and a higher 407 
duration of subfertility compared to couples who continued expectant management, the large 408 
sample size of treated and untreated couples resulted in sufficient overlap of case-mix to 409 
enable us to accurately estimate all the separate interactions between patient characteristics 410 
and treatment. A second strength was our ability to control for confounding in the average 411 
adjusted chance by matching on female age, duration of subfertility and primary versus 412 
secondary subfertility. 413 
We were able to predict individualised chances of conception following either IVF or 414 
expectant management on the same time axis representing one year of ‘real’ calendar time. 415 
This is intuitive, allows for a straightforward comparison, allows for most couples to complete 416 
at least one full IVF cycle and is easier to communicate to patients compared to chances per 417 
embryo transfer or per IVF cycle. A longer follow up might increase the rates after both IVF 418 
and expectant management but may be more difficult for decision making, as the longer the 419 
follow up period becomes, the less likely couples are to continue IVF. 420 
Aside from calculating the observed fraction of couples who conceived within one 421 
year in the matched data (approximately 48%), we also estimated the adjusted chance of 422 
conception when receiving IVF for one full year i.e. when continuing IVF (approximately 423 
60%). The latter might be an optimistic estimate, as not all couples can continue with 424 
additional IVF cycles, for instance because of an insufficient number of oocytes or financial 425 
reasons. 426 
 427 
Limitations of this study include the availability of only three important patient characteristics 428 
in all data sources, the missing date of completion of the fertility workup in the Scottish data 429 
and the possibility of residual confounding due to the observational nature of the data. We 430 
had to make an assumption on the time between registration and completion of the fertility 431 
workup in the Scottish cohort. In the Dutch cohort, this was on average six weeks (van 432 
Eekelen et al., 2019). In a previously conducted validation study, we found similar chances of 433 
ongoing pregnancy in the Scottish and Dutch cohort when assuming six weeks between 434 
registration and completion of the fertility workup, hence this assumption was deemed 435 
reasonable (van Eekelen et al., 2019). The dropout rate after the first embryo transfer of 21% 436 
is higher than the 12% reported in a recent Dutch validation study, but the difference can be 437 
explained by the geographical variation in reimbursement for the UK IVF cohort compared to 438 
full reimbursement up to three cycles at the time of the Dutch study (Leijdekkers et al., 2018). 439 
In addition, the three different data sources used different sampling mechanisms, which 440 
could potentially compromise the comparability of study populations. Couples pursuing 441 
expectant management were recruited at completion of the fertility workup (Dutch cohort) or 442 
identified retrospectively (Scottish cohort). In contrast, couples who received IVF were 443 
registered in the UK IVF database with no prior data other than diagnosis. Therefore we were 444 
unable to assess or adjust for any selection bias that might occur between completion of the 445 
fertility workup and the start of treatment, as only couples that did not conceive naturally 446 
during that period will have ended up in the UK IVF registry, a selection which might not be 447 
fully captured by the duration of subfertility (van Eekelen et al., 2017b). 448 
 As the UK IVF data were only available up to 2011 and treatment success rates were 449 
found to increase over time, our estimates for the one year chance after IVF might be 450 
conservative for today’s practice. However, IVF rates in the UK in 2016 were found to 451 
plateau in 2013 to 25%-26% per cycle (HFEA, 2016; HFEA, 2018). A recent external 452 
validation of the OPiS model developed on UK IVF data up to 2008 showed good 453 
performance in Dutch data collected up to 2014, meaning that our data might reasonably 454 
reflect today’s practice and pregnancy outcomes (McLernon et al., 2016; Leijdekkers et al., 455 
2018). The decade has witnessed changes in embryo transfer protocols in the UK from 456 
predominantly double embryo transfer (DET) to increasing numbers of elective single embryo 457 
transfer (eSET) resulting in a decline in  multiple pregnancy rates from 27% in 2008 to16% in 458 
2014 (Harbottle et al., 2015; HFEA, 2015). Nevertheless, the impact of this change in IVF 459 
policy on our estimated chances of conception might be minor as the cumulative chances of 460 
IVF success are comparable following DET and eSET combined with subsequent transfers 461 
of frozen/thawed embryos (Lukassen et al., 2005; McLernon et al., 2010; Harbottle et al., 462 
2015). 463 
The primary outcome was ongoing pregnancy because the increased logistical efforts 464 
and associated costs involved in following couples to delivery was not possible in the Dutch 465 
cohort. Ongoing pregnancy is generally considered an appropriate proxy for live birth in 466 
clinical research: approximately 95% of ongoing pregnancies lead to live birth (Clarke et al., 467 
2010; Braakhekke et al., 2014). 468 
A large RCT would be the ideal study design to assess the effectiveness of IVF 469 
compared to expectant management. Conducting such a trial now would be challenging as 470 
IVF has become an established treatment for unexplained subfertility and many couples are 471 
unconfident about the value of expectant management, overestimate IVF success and push 472 
for early active treatment (van den Boogaard et al., 2011; Kersten et al., 2015). In addition, 473 
many clinicians fail to take into account couples’ chances of natural conception in their 474 
consultations and believe that it would be unethical to withhold early access to IVF (Kersten 475 
et al., 2015). This has created a genuine lack of equipoise without which no trial can be 476 
conducted. We therefore felt that the best and most pragmatic option was to compare 477 
observational data from cohorts on expectant management and IVF (van Eekelen et al., 478 
2017b). 479 
 480 
A key benefit of the present study is the provision of the adjusted average effectiveness of 481 
IVF compared to expectant management and, in addition, individualised estimates which are 482 
easy to interpret and allow for direct comparisons. 483 
Our results may be used by clinicians to counsel couples with unexplained subfertility to 484 
inform their expectations and to avoid unnecessary treatment for some whilst allowing timely 485 
access to IVF for others. They can also be used to allow funders and commissioners to make 486 
decisions on access to publicly funded IVF. 487 
Our results need to be validated in other datasets or, ideally, in RCTs involving couples with 488 
characteristics in whom the effectiveness of IVF is unclear and some equipoise remains. In 489 
addition, data on long term follow up after the first live birth is necessary to counsel couples 490 
who wish to have multiple children. 491 
 492 
Conclusion 493 
The effectiveness of IVF over expectant management in unexplained subfertility depends on 494 
the characteristics of the couple. IVF should be used selectively in those who have the most 495 
to gain from active treatment over expectant management. Our results can be used by 496 
clinicians to counsel couples with unexplained subfertility, to inform their expectations and 497 
facilitate evidence-based, shared decision making. 498 
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 690 
Table I. Baseline characteristics at the start of follow up for the three cohorts included 691 
in the analysis. 692 
 693 
 UK IVF (n=40.921) Dutch (n=4.875) Scottish (n=975) 
Female age 
(mean, 5th-95th percentile) 
35.1 (28-42) 32.5 (24.9-39.4) 33.2 (26.1-41.1) 
Duration of subfertility 
(median, 5th-95th percentile) 
4.0 (1-13) 1.6 (1-4.9) 2.1 (1.1-5.1) 
Primary subfertility (n, %) 24572 (60%) 3231 (66%) 571 (59%) 
 694 
 695 
Table II. Estimated effects of patient characteristics on conception leading to ongoing 696 
pregnancy. Results are from the model including interaction (via stratification) with 697 
treatment. 698 
 Hazard ratio for 
conception after IVF 
(95%CI) 
Hazard ratio for 
conception after expectant 
management (95%CI) 
Female age, years (34 versus 27)* 0.99 (0.94-1.04) 0.70 (0.60-0.82) 
Female age, years (40 versus 35)* 0.43 (0.41-0.46) 0.64 (0.49-0.84) 
Duration of subfertility, years (6 versus 2)* 0.86 (0.80-0.92) 0.39 (0.30-0.50) 
Primary versus secondary subfertility 0.98 (0.94-1.02) 0.71 (0.63-0.81) 
*Contrasts between values for female age and duration of subfertility were chosen to depict their non-699 
linear estimated effects. 700 
 701 
Table III. Association between primary or secondary subfertility and the one year 702 
chance of conception after receiving IVF or pursuing expectant management for a 703 
couple of which the woman is 35 years old who have been trying to conceive for 2 704 
years 705 
 706 
 One year chance of 
conception after IVF (95%CI) 
One year chance of conception after 
expectant management (95%CI) 
Primary subfertile couple 49.2 (46.3-52.1) 19.9 (16.7-23.1) 
Secondary subfertile couple 50.0 (47.0-53.0) 26.7 (22.2-31.2) 
707 
Figure 1. Flowchart of recruitment and inclusion/exclusion in the three cohorts 708 
 709 
 A. UK IVF                                B. Dutch                              C. Scottish 710 
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 725 
41.317 couples with IVF 
treatment 
 from 1998 to 2011 
40.921 unexplained subfertile 
couples eligible for analysis 
 
147.040 couples received IVF 
treatment in the UK between 
January 1999 and June 2011 
6.993 couples with complete 
outcome data 
4.875 unexplained subfertile 
couples eligible for analysis 
 
7.860 couples included in Dutch 
national cohort study between 
2002 and 2004 
 
1.113 couples from Aberdeen 
with complete outcome data 
975 unexplained subfertile couple 
 eligible for analysis 
 
2.126 couples registered in 
Aberdeen Fertility Clinic between 
1998 and 2015 and categorized as 
unexplained subfertile 
Exclusion of couples who did not 
provide consent for use their IVF 
treatment data (n=20) and couples 
from other regions than 
Aberdeen City District (n=993) 
 
Exclusion of couples with duration 
of subfertility less than one year 
(n=46) and couples who conceived 
before the fertility workup 
was completed (n=92) 
 
Exclusion of couples who had 
missing outcome data (n=867) 
 
Exclusion of couples who 
had diagnoses other than 
unexplained subfertility 
(n=1.828) and couples 
with one-sided tubal 
pathology (n=290) 
Exclusion of couples with 
duration of subfertility less 
than one year (n=396) 
Exclusion of couples with 
diagnoses other than 
unexplained subfertility 
(n=105.723)  
 
 
 
Figure 2. Overlap of patient characteristics for couples who received IVF and couples 726 
who pursued expectant management 727 
 728 
A. Distribution of female age per treatment group, depicted by relative frequency 729 
(density) 730 
 731 
 732 
 733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
 741 
 742 
B. Distribution of duration of subfertility per treatment group, depicted as the 743 
proportion of couples per group who had a certain (rounded) duration 744 
  745 
Figure 3. Association between female age and the one year chance of conception after 746 
receiving IVF or pursuing expectant management for a primary subfertile couple who 747 
have been trying to conceive for 2 years. Grey bands are 95% confidence limits 748 
  749 
Figure 4. Association between duration of subfertility and the one year chance of 750 
conception receiving IVF or pursuing expectant management for a primary subfertile 751 
couple of which the woman is 35 years old. Grey bands are 95% confidence limits 752 
 753 
 754 
